West Asia Conflict Disrupts Global Pharma Supply Chains, Exposing India And ASEAN Healthcare Vulnerabilities
The conflict in West Asia has disrupted global pharmaceutical supply chains, affecting India and ASEAN healthcare systems. The disruption has led to logistical bottlenecks, potential losses, and rising production costs for pharmaceutical companies, as well as concerns over medicine shortages and price increases in Southeast Asia.
A conflict in West Asia has disrupted global pharmaceutical supply chains. The Strait of Hormuz closure has affected petrochemical shipments, a key link in the pharmaceutical supply chain. India's pharmaceutical exports face logistical bottlenecks and potential losses. Healthcare systems in Southeast Asia, dependent on imported medicines, face higher procurement costs and shipping delays. Thailand and Malaysia have limited medicine stocks, with contingency plans in place to source alternatives from India, China, and Europe. Indian hospitals are pivoting towards Southeast Asia due to a decline in international patients from West Asia.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.